AG002FV4

192374-14-4 | 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-

Chemical structure of 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-, CAS 192374-14-4
AG002FV4
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 192374-14-4
Catalog Number AG002FV4(AGN-PC-0O69CE)
Chemical Name 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-
IUPAC Name (2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol
InChI InChI=1S/C13H18ClNO2/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3/t9-,13+/m0/s1
InChI Key RCOBKSKAZMVBHT-TVQRCGJNSA-N
MDL Number MFCD12911693
Molecular Formula C13H19Cl2NO2
Molecular Weight 292.2015
SMILES Cl.C[C@@H]1NC(C)(C)CO[C@@]1(O)c2cccc(Cl)c2
UNII Q47741214K
Synonyms
2-morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-, radafaxine, Radafaxine, 192374-14-4, (S,S)-Hydroxy Bupropion, UNII-Q47741214K, CHEMBL1172928, GW 353162, 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-, Q47741214K, (2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol, (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol, Radafaxine [INN], Hydroxybupropion (as (RS,RS)-cyclic Hemiketal), 233600-52-7, (s,s)-hydroxybupropion, (2s,3s)-hydroxybupropion, SCHEMBL48964, CTK8E8317, RCOBKSKAZMVBHT-TVQRCGJNSA-N, ZINC5377133, BDBM50322532, AKOS030254719, DB11790, RT-013174, FT-0669437, J-012438, (2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol, (2S-cis)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol, 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S-cis)-, CID9795056, C496215, 2-(3-chlorophenyl)-3,5,5-trimethyl-morpholin-2-ol, 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-,(2S,3S)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited